Rafael Gonzalez-Manzanares
@rafaelglezm
Followers
924
Following
4K
Media
88
Statuses
1K
MD PhD | Cardiologist & researcher @HUReinaSofia @IMIBIC @CIBER_CV | MSc Stats @UCL | Juan Rodés @SaludISCIII | Board @JovenesSEC | #RCTs #HF #CardioOnc
Córdoba, Andalucía
Joined February 2018
Happy to announce that I have been granted a Juan Rodes @SaludISCIII physician-scientist contract. A milestone in my career that would not have been possible without the support of my mentors at @Cardio_HURS, friends, family, María… and of course, a lot of hard work! 🔬💻🩺
31
13
125
RT @JTLLERGO: ⚠️ Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity‼️. ✅ Cangrilide-Sema ⬇️ –20.4% percent ch….
0
14
0
RT @RevEspCardiol: Rationale and design of the beta-blockers in tako-tsubo syndrome study: a randomized clinical trial (β-Tako) #REC @ibnsk….
0
8
0
Interesting paper from SJLIFE. Last year, we described subtle changes in diastolic function in the CTOXALL cohort, which we hypothesized were related to accelerated aging caused by cancer therapies. Our findings were published in @RevEspCardiol .🔗
Childhood #cancersurvivors face higher cardiometabolic and #heartdisease risks due to epigenetic age acceleration (EAA) from prior treatments. A study by @DrBonnieKy 🩺 et al. explores how EAA may mediate this link. ➡️ #CardioOncology #PennThalheimer
1
9
12
RT @marikillacs: 🎉 Exciting news!. Our latest research article has just been published!. 🔗 Read the full article here: .
mdpi.com
(1) Background and aim: The benefit of surgical treatment compared to conservative management is unclear in degenerative cuff tears, and there is limited evidence regarding midterm functional...
0
2
0
RT @HUReinaSofia: 📣 Nuestra cardióloga @OjedaOjeda18 tiene desde el pasado miércoles 16 de julio una calle con su nombre en el municipio de….
0
7
0
RT @RevEspCardiol: Justificación y diseño del estudio sobre bloqueadores beta en el síndrome de tako-tsubo: un estudio clínico aleatorizado….
0
6
0
RT @RevEspCardiol: Acoplamiento entre el ventrículo derecho y la arteria pulmonar como predictor de muerte o ingreso por IC en pacientes co….
0
7
0
RT @cardioteca: 3️⃣ Preguntas Sobre. el impacto de la revascularización de oclusiones coronarias crónicas .☝️ ¿De qué trata tu investigac….
0
10
0
RT @SanchoLab: 💥 A gut microbe metabolite that drives #atherosclerosis?.Yes—Imidazole propionate (ImP) triggers vascular inflammation witho….
nature.com
Nature - Imidazole propionate produced by gut microbiota is associated with atherosclerosis in mouse models and in humans, and causes the development of atherosclerosis through activation of the...
0
155
0
RT @GSCollins: NEW PAPER in @bmj_latest "Dealing with continuous variables and modelling non-linear associations in healthcare data: pract….
0
109
0
RT @OjedaOjeda18: Emocionada y agradecida por este regalazo! Gracias por tanto cariño! #Moriles ❤️
0
27
0
RT @acorderofort: Hot Lines of #Esccongress2025 have just been revealed!!!.Come on @Borjaibanez1 @RoselloXavier and @RebootTrial !!! .@esc….
0
3
0
RT @MAROSFO: La formación que se hace con pasión, esfuerzo e innovación tiene mucho más éxito. De esto sabe mucho @almucastro01 .Gracias po….
0
3
0
RT @HUReinaSofia: 🏥📄🧑⚕ @HUReinaSofia e @IMIBIC lideran un nuevo estudio que demuestra que retirar los diuréticos en pacientes estables con….
0
15
0